Cited by 238Extracellular vesicles in diseaseRNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Exosome-mediated delivery of gene vectors for gene therapy

Open access
Duan, Li, Xu, Limei, Xu, Xiao, Qin, Zhuan, Zhou, Xiaoying, Xiao, Yin, Liang, Yujie, Xia, Jiang·2021·Nanoscale

Abstract

Exosome encapsulation protects and delivers AAV vectors for gene therapy.

Integrity signals

Registry

Crossref · 10.1039/d0nr07622h

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two main approaches can be used to enhance targeting ability of exosomes: direct chemical modification or indirect genetic engineering.

    “Two main approaches can be used to enhance the targeting ability of exosomes for specific applications: direct modification of exosomes by chemical means or, indirect manipulation of the donor cells through genetic engineering techniques [89, 103, 118–120]”

The citation lists haven’t been fetched yet

References 74 · Cited by 238

Authors
Duan, L., Xu, L., Xu, X., Qin, Z., Zhou, X., Xiao, Y., Liang, Y., & Xia, J.
Affiliations
  • Shenzhen University Health Science Center (CN)
  • Queensland University of Technology (AU)
  • Shenzhen KangNing Hospital (CN)
  • Chinese University of Hong Kong (HK)
Corresponding author
  • Liang, Yujie
  • Xia, Jiang
Venue
Nanoscale
Published
2021
Volume
13
Issue
3
Pages
1387-1397
ISSN
  • 2040-3364 (ISSN-L)
  • 2040-3372
OpenAlex
W3112346014
Cited by
238
References
74
Citations by year
2026: 15 · 2025: 41 · 2024: 42 · 2023: 69 · 2022: 54 · 2021: 16 · 2012: 1
FWCI
3.33
Type
journal article
Language
en
Open access
Locations
  • Nanoscale (publishedVersion)
  • PubMed (publishedVersion)
  • Griffith Research Online (submittedVersion, other-oa)
Funders
  • National Natural Science Foundation of China (81772394, 81972116)
  • Natural Science Foundation of Guangdong Province (2018B0303110003, 2020A1515011581)
  • Shenzhen Science and Technology Innovation Program (KQTD20170331100838136, JCYJ20180306170922163, JCYJ20200109150700942, JCYJ20170413161649437, JCYJ20170817172023838)
  • Chinese University of Hong Kong
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
exosomes, gene delivery vectors, gene therapy, nucleic acid carriers, exosome engineering, targeted delivery
MeSH terms
Genetic Vectors, Liposomes, Genetic Therapy, Drug Delivery Systems, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review